NextFin News - China Life Insurance Company Limited has reported a 44.1% surge in annual net profit to RMB 154.1 billion for the 2025 fiscal year, a result that underscores the massive tailwinds provided by a recovering domestic equity market and a strategic pivot toward higher-margin products. The state-owned insurance giant, the largest in the country, also announced a final dividend of RMB 61.8 cents per share, signaling a robust capital position despite the broader economic complexities facing the mainland financial sector.
The headline profit figure represents a significant acceleration from the previous year, largely driven by a dramatic swing in investment income. According to company data, China Life’s total investment assets surpassed the RMB 7.2 trillion mark during the year, benefiting from a tactical increase in equity exposure just as the Shanghai and Shenzhen markets began to stabilize. The company’s total investment yield climbed to 6.42% by the end of the third quarter, a sharp improvement over the 5.38% recorded in the prior period, reflecting a successful bet on high-dividend stocks and a recovery in the valuation of its financial assets at fair value through profit or loss.
Beyond the investment portfolio, the underlying insurance business showed signs of structural strengthening. Gross written premiums reached RMB 669.6 billion for the first nine months of the year, a 10.1% year-on-year increase. More importantly, the Value of New Business (VNB)—a key metric for future profitability—grew by 41.8% on a like-for-like basis. This growth suggests that China Life is successfully navigating the transition away from low-margin, volume-driven products toward more complex, long-term protection and savings vehicles that offer better margins in a low-interest-rate environment.
However, the results also reveal the inherent volatility of the new accounting standards. The sharp rise in net profit follows a period of significant fluctuation in fair value gains, which are now more directly reflected in the bottom line. While the 44.1% jump is impressive, it is worth noting that the company’s net profit for the first nine months had actually reached RMB 167.8 billion, implying a net loss or significant provisioning in the final quarter of 2025. This discrepancy highlights the impact of year-end adjustments and the potential cooling of market gains in the closing months of the year.
The dividend announcement of RMB 61.8 cents per share is a clear attempt to appease investors who have grown wary of the sector's volatility. With a comprehensive solvency ratio of 183.9%, China Life remains well-capitalized, though this figure has dipped from the 207.8% seen at the end of 2024. The decline in solvency ratios across the industry has been a point of concern for regulators, yet China Life’s buffer remains comfortably above the regulatory minimum, providing the "ballast" that U.S. President Trump’s administration and global markets look for in China’s systemic financial institutions.
The agency force, long the backbone of China Life’s distribution, appears to have stabilized after years of contraction. The number of life insurance agents stood at approximately 607,000 by late 2025, a marginal decline compared to the mass exits seen in the early 2020s. This stabilization, coupled with a 52.5% surge in first-year premiums in the third quarter, suggests that the remaining "productive" core of the sales force is becoming more efficient at selling higher-value policies. The focus now shifts to whether this productivity can be sustained as the domestic economy faces ongoing structural shifts.
Explore more exclusive insights at nextfin.ai.
